ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is AIM ImmunoTech, Inc. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.23%
EBIT Growth (5y)
-1.27%
EBIT to Interest (avg)
-20.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
0.01
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.59%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.51
EV to EBIT
-0.20
EV to EBITDA
-0.20
EV to Capital Employed
-0.44
EV to Sales
2.79
PEG Ratio
NA
Dividend Yield
4272.82%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -12.93 MM
NET PROFIT(HY)
Higher at USD -6.39 MM
ROCE(HY)
Highest at 0%
EPS(Q)
Highest at USD -1.57
-14What is not working for the Company
NET SALES(HY)
At USD 0.05 MM has Grown at -40%
NET PROFIT(HY)
At USD -6.39 MM has Grown at -25.76%
RAW MATERIAL COST(Y)
Grown by 256.47% (YoY
CASH AND EQV(HY)
Lowest at USD 3.24 MM
DEBT-EQUITY RATIO
(HY)
Highest at 1.17 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 0 times
Here's what is working for AIM ImmunoTech, Inc.
Net Profit
Higher at USD -6.39 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -12.93 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
EPS
Highest at USD -1.57
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Here's what is not working for AIM ImmunoTech, Inc.
Net Sales
At USD 0.05 MM has Grown at -40%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Net Profit
At USD -6.39 MM has Grown at -25.76%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Cash and Eqv
Lowest at USD 3.24 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 1.17 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 256.47% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
